PBA

Paradigm Biocapital Advisors Portfolio holdings

AUM $3.73B
1-Year Est. Return 133.76%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+133.76%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.61B
AUM Growth
-$228M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
44
New
Increased
Reduced
Closed

Top Buys

1
+$97.8M
2
+$87.6M
3
+$73.5M
4
BBIO icon
BridgeBio Pharma
BBIO
+$29.8M
5
KURA icon
Kura Oncology
KURA
+$28.9M

Top Sells

1
+$116M
2
+$84.1M
3
+$80.8M
4
PCVX icon
Vaxcyte
PCVX
+$41.7M
5
AUTL
Autolus Therapeutics
AUTL
+$41M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$26.9M 1.03%
1,542,805
+194,790
27
$17.1M 0.65%
+7,250,000
28
$14.1M 0.54%
2,335,926
-55,062
29
$13M 0.5%
330,000
30
$10.4M 0.4%
+721,087
31
$9.5M 0.36%
+1,575,605
32
$9.17M 0.35%
+919,692
33
$6.46M 0.25%
322,865
34
$3.83M 0.15%
+659,724
35
$2.07M 0.08%
+353,886
36
– –
-6,425,803
37
– –
-3,246,759
38
– –
-2,172,620
39
– –
-147,959
40
– –
-1,787,176
41
– –
-944,917
42
– –
-50,000
43
– –
-2,121,163
44
– –
-400,000
1
2